Article info
PDFDTB select
EMA advice on renin-angiotensin system medicines during covid-19 pandemic
Citation
EMA advice on renin-angiotensin system medicines during covid-19 pandemic
Publication history
- First published April 15, 2020.
Online issue publication
December 17, 2020
Article Versions
- Previous version (17 December 2020).
- Previous version (17 December 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage